Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2018, Article ID 3864398, 6 pages
https://doi.org/10.1155/2018/3864398
Research Article

Association of Peripheral Monocyte Count with Soluble P-Selectin and Advanced Stages in Nasopharyngeal Carcinoma

Internal Medicine Department, Faculty of Medicine, Universitas Indonesia, Salemba Raya 6, Central Jakarta 10430, Indonesia

Correspondence should be addressed to Adi Surya Komala; di.ca.iu.inmula@17ayrus.ida

Received 11 October 2017; Revised 25 January 2018; Accepted 5 February 2018; Published 5 March 2018

Academic Editor: Bashir A. Lwaleed

Copyright © 2018 Adi Surya Komala and Andhika Rachman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. F. H. Chong and C. K. Ong, “Nasopharyngeal carcinoma,” European Journal of Radiology, vol. 66, no. 3, pp. 437–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. T. C. Chan, “Nasopharyngeal carcinoma,” Annals of Oncology, vol. 21, pp. 308–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Adham, A. N. Kurniawan, A. I. Muhtadi et al., “Nasopharyngeal carcinoma in indonesia: Epidemiology, incidence, signs, and symptoms at presentation,” Chinese Journal of Cancer, vol. 31, no. 4, pp. 185–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. K. Gospodarowicz, D. Miller, P. A. Groome, F. L. Greene, P. A. Logan, and L. H. Sobin, “The process for continuous improvement of the TNM classification,” Cancer, vol. 100, no. 1, pp. 1–5, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Kang, J. Long, G. Li, H. Yan, G. Feng, M. Liu et al., “A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study,” Oncotarget, vol. 7, no. 12, pp. 15252–15261, 2016. View at Google Scholar
  6. R. Sud and A. A. Khorana, “Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model,” Thrombosis Research, vol. 123, no. 4, pp. S18–S21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. E. Sutherland, I. C. Weitz, and H. A. Liebman, “Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment,” American Journal of Hematology, vol. 72, no. 1, pp. 43–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Donnellan, B. Kevane, B. R. Healey Bird, and F. Ni Ainle, “Cancer and venous thromboembolic disease: From molecular mechanisms to clinical management,” Current Oncology, vol. 21, no. 3, pp. 134–143, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Paneesha, A. McManus, R. Arya et al., “Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics,” Thrombosis and Haemostasis, vol. 103, no. 2, pp. 338–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Khorana, “PL-02 risk assessment for cancer-associated thrombosis: What is the best approach?” Thrombosis Research, vol. 129, no. 1, pp. S10–S15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Ay, R. Vormittag, D. Dunkler et al., “D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study,” Journal of Clinical Oncology, vol. 27, no. 25, pp. 4124–4129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Khorana and G. C. Connolly, “Assessing risk of venous thromboembolism in the patient with cancer,” Journal of Clinical Oncology, vol. 27, no. 29, pp. 4839–4847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. A. Fox and S. R. Kahn, “The relationship between inflammation and venous thrombosis. A systematic review of clinical studies,” Thrombosis and Haemostasis, vol. 94, no. 2, pp. 362–365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Aksu, A. Donmez, and G. Keser, “Inflammation-induced thrombosis: Mechanisms, disease associations and management,” Current Pharmaceutical Design, vol. 18, no. 11, pp. 1478–1493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. T. Esmon, “Reprint of Crosstalk between inflammation and thrombosis,” Maturitas, vol. 61, no. 1-2, pp. 122–131, 2008. View at Publisher · View at Google Scholar
  16. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Candido and T. Hagemann, “Cancer-related inflammation,” Journal of Clinical Immunology, vol. 33, supplement 1, pp. S79–S84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. I. Diakos, K. A. Charles, D. C. McMillan, and S. J. Clarke, “Cancer-related inflammation and treatment effectiveness,” The Lancet Oncology, vol. 15, no. 11, pp. e493–e503, 2014. View at Publisher · View at Google Scholar
  20. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani, “Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability,” Carcinogenesis, vol. 30, no. 7, pp. 1073–1081, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Mantovani, C. Garlanda, and P. Allavena, “Molecular pathways and targets in cancer-related inflammation,” Annals of Medicine, vol. 42, no. 3, pp. 161–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. E. Langley, S. Burdett, J. F. Tierney, F. Cafferty, M. K. B. Parmar, and G. Venning, “Aspirin and cancer: Has aspirin been overlooked as an adjuvant therapy,” British Journal of Cancer, vol. 105, no. 8, pp. 1107–1113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. V. Jakubzick, G. J. Randolph, and P. M. Henson, “Monocyte differentiation and antigen-presenting functions,” Nature Reviews Immunology, vol. 17, no. 6, pp. 349–362, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Porta, P. Larghi, M. Rimoldi et al., “Cellular and molecular pathways linking inflammation and cancer,” Immunobiology, vol. 214, no. 9-10, pp. 761–777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Li, R. Jiang, W.-S. Liu et al., “A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma,” PLoS ONE, vol. 8, no. 12, Article ID e83069, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Ay, R. Simanek, R. Vormittag et al., “High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: Results from the Vienna Cancer and Thrombosis Study (CATS),” Blood, vol. 112, no. 7, pp. 2703–2708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Jiang, X.-Y. Cai, Z.-H. Yang et al., “Elevated peripheral blood lymphocyteto-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma,” Chinese Journal of Cancer, vol. 34, no. 6, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. E. T. Chang and H. Adami, “The enigmatic epidemiology of nasopharyngeal carcinoma,” Cancer Epidemiology, Biomarkers & Prevention, vol. 15, no. 10, pp. 1765–1777, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Riedl, L. Hell, A. Kaider et al., “Association of platelet activation markers with cancer-associated venous thromboembolism,” Platelets, vol. 27, no. 1, pp. 80–85, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Falanga, L. Russo, and V. Milesi, “The coagulopathy of cancer,” Current Opinion in Hematology, vol. 21, no. 5, pp. 423–429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. G. C. Connoly and A. A. Khorana, “Risk stratification for cancer-associated venous thromboembolism,” Best Practice & Research Clinical Haematology, vol. 22, pp. 35–47, 2009. View at Google Scholar
  32. P. André, “P-selectin in haemostasis,” British Journal of Haematology, vol. 126, no. 3, pp. 298–306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Ferroni, F. Martini, S. Riondino et al., “Soluble P-selectin as a marker of in vivo platelet activation,” Clinica Chimica Acta, vol. 399, no. 1-2, pp. 88–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. M. Richards, J. Hettinger, and M. Feuerer, “Monocytes and macrophages in cancer: Development and functions,” Cancer Microenvironment, vol. 6, no. 2, pp. 179–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Huang, X. Liu, F. Zhao et al., “M2-polarized tumour-associated macrophages in stroma correlate with poor prognosis and Epstein–Barr viral infection in nasopharyngeal carcinoma,” Acta Oto-Laryngologica, vol. 137, no. 8, pp. 888–894, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. S. A. Stacker, S. P. Williams, T. Karnezis, R. Shayan, S. B. Fox, and M. G. Achen, “Lymphangiogenesis and lymphatic vessel remodelling in cancer,” Nature Reviews Cancer, vol. 14, no. 3, pp. 159–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Saaristo, T. Tammela, A. Fārkkilā et al., “Vascular endothelial growth factor-C accelerates diabetic wound healing,” The American Journal of Pathology, vol. 169, no. 3, pp. 1080–1087, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. C. R. Leemans, R. Tiwari, J. P. J. Nauta, I. Van der Waal, and G. B. Snow, “Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma,” Cancer, vol. 71, no. 2, pp. 452–456, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. M.-L. von Brühl, K. Stark, A. Steinhart et al., “Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo,” The Journal of Experimental Medicine, vol. 209, no. 4, pp. 819–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Shantsila and G. Y. H. Lip, “The role of monocytes in thrombotic disorders: insights from tissue factor, monocyte-platelet aggregates and novel mechanisms,” Thrombosis and Haemostasis, vol. 102, no. 5, pp. 916–924, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Cafolla, “Monocyte value could be a thrombosis marker?” Thrombosis Research, vol. 133S3, pp. S95–S96, 2014. View at Google Scholar